Elevance Health (NYSE:ELV) 주식

ELEVANCE HEALTH INC

Elevance Health

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

Washington,Dc,,United,States,,March,21,2025:president,Donald,Trump,Stops

Government

Large Cap

News

Regulations

Health Care

Politics

Movers

Tech

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

ENPH

FSLR

PLTR

도널드 트럼프 대통령의 대규모 입법안은 예상대로 분열을 일으키고 있다. 공화당은 &#34;하나의 크고 아름다운 법안&#34;(One, Big Beautiful Bill)이라고 홍보하고 있지만 민주당은 &#34;하나의 크고 아름다운 배신&#34;이라고 부르고 있다. 이 법안의 주요 내용을 몇 가지 살펴보자. 

트럼프의 대규모 입법안 &#39;크고 아름다운 법안&#39;에 영향 받을 종목은?

Trump Has Asked Me To Do 3 Things, Says Robert Kennedy Jr.

iShares Dow Jones US Health Care Provides Index Fund

MRNA

로버트 F. 케네디 주니어가 미국 보건복지부(HHS) 장관으로 취임했다. 이는 건강보험 주식과 이를 보유한 ETF를 포함한 의료 부문에 큰 변화를 가져올 수 있다.

RFK 주니어의 美 보건복지부 장관 취임, 주목해야 할 건강보험 ETF는?

Humana

Analyst Color

Earnings Beats

Guidance

Analyst Ratings

General

미국의 의료 보험 회사 휴매나(NYSE:HUM)의 주식은 수요일 소폭 상승 마감했다. 화요일 이 회사는 4분기 조정 주당순이익이 2.16달러 손실이라고 발표했다. 이는 전년 대비 11센트 감소한 수치로, 컨센서스와 일치하며 별 등급제에 대한 추가 투자를 포함한 것이다.

휴매나의 2025 전망, 산업 압박에도 불구하고 조심스러운 낙관론을 보여

Elevance Health Inc

Electrovaya Inc

Evolva Holding SA

Evolva Holding SA ADR

ELVICTOR GROUP INC by Elvictor Group, Inc

Elvictor Group Inc

Enliven Therapeutics, Inc. - Common Stock

Enliven Therapeutics Inc

ELEVATE URANIUM LTD by Elevate Uranium Ltd.

Elevate Uranium Ltd

EVOLVA HLDG AG S/ADR by Evolva Holding AG

Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) reported quarterly losses of $(0.17) per share. This is a 59.52 percent increase over losses of $(0.42) per share from the same period last year. The company reported $3.70 million in sales this quarter. This is a 9.86 percent decrease over sales of $4.11 million the same period last year.

Earnings

HCTI

Healthcare Triangle Q1 EPS $(0.17) Up From $(0.42) YoY, Sales $3.70M Down From $4.11M YoY

FinVolution Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FINV#NYSE">FINV</a>) reported quarterly earnings of $0.41 per share. This is a 41.38 percent increase over earnings of $0.29 per share from the same period last year. The company reported $479.70 million in sales this quarter. This is a 9.43 percent increase over sales of $438.36 million the same period last year.

FINV

FinVolution Gr Q1 Adj. EPS $0.41 Up From $0.29 YoY, Sales $479.70M Up From $438.36M YoY

Micromobility com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCOM#NASDAQ">MCOM</a>) reported $477.00 thousand in sales this quarter. This is a 16.46 percent decrease over sales of $571.00 thousand the same period last year.

MCOM

Micromobility com Q1 Sales $477.00K Down From $571.00K YoY

ZTO Express (Cayman) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZTO#NYSE">ZTO</a>) reported quarterly earnings of $0.37 per share. This is unchanged from the same period last year. The company reported $1.50 billion in sales this quarter. This is a 8.85 percent increase over sales of $1.38 billion the same period last year.

ZTO Express (Cayman) Q1 Adj. EPS $0.37, Same YoY, Sales $1.50B Up From $1.38B YoY

FOXO Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#AMEX">FOXO</a>) reported quarterly losses of $(0.37) per share. This is a 54.17 percent decrease over losses of $(0.24) per share from the same period last year. The company reported $3.17 million in sales this quarter. This is a 45.18K percent increase over sales of $7.00 thousand the same period last year.

FOXO

FOXO Technologies Q1 EPS $(0.37) Down From $(0.24) YoY, Sales $3.17M Up From $7.00K YoY

CFSB

Hometown Financial Group To Acquire CFSB Bancorp For A Total Transaction Value Of ~$44M

Mesa Air Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESA#NASDAQ">MESA</a>) reported quarterly losses of $(0.07) per share. This is a 146.67 percent decrease over earnings of $0.15 per share from the same period last year. The company reported $94.75 million in sales this quarter. This is a 27.99 percent decrease over sales of $131.58 million the same period last year.

MESA

Mesa Air Gr Q2 Adj. EPS $(0.07) Down From $0.15 YoY, Sales $94.75M Down From $131.58M YoY

ZW Data Action Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNET#NASDAQ">CNET</a>) reported quarterly losses of $(0.23) per share. This is a 52.08 percent increase over losses of $(0.48) per share from the same period last year. The company reported $1.65 million in sales this quarter. This is a 53.21 percent decrease over sales of $3.53 million the same period last year.

CNET

ZW Data Action Tech Q1 EPS $(0.23) Up From $(0.48) YoY, Sales $1.65M Down From $3.53M YoY

Global Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GITS#NASDAQ">GITS</a>) reported quarterly losses of $(0.20) per share. This is a 50 percent increase over losses of $(0.40) per share from the same period last year.

GITS

Global Interactive Q1 EPS $(0.20) Up From $(0.40) YoY

MediaCo Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDIA#NASDAQ">MDIA</a>) reported quarterly losses of $(0.12) per share. This is a 33.33 percent increase over losses of $(0.18) per share from the same period last year. The company reported $28.03 million in sales this quarter. This is a 317.98 percent increase over sales of $6.71 million the same period last year.

MDIA

MediaCo Holding Q1 EPS $(0.12) Up From $(0.18) YoY, Sales $28.03M Up From $6.71M YoY

Massimo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAMO#NASDAQ">MAMO</a>) reported quarterly losses of $(0.05) per share. This is a 162.5 percent decrease over earnings of $0.08 per share from the same period last year. The company reported $14.90 million in sales this quarter. This is a 50.58 percent decrease over sales of $30.15 million the same period last year.

MAMO

Massimo Q1 EPS $(0.05) Down From $0.08 YoY, Sales $14.90M Down From $30.15M YoY

Mobile Global Esports (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGAM#NASDAQ">MGAM</a>) reported quarterly losses of $(0.01) per share. This is a 66.67 percent increase over losses of $(0.03) per share from the same period last year. The company reported $1.56 thousand in sales this quarter.

MGAM

Mobile Global Esports Q1 EPS $(0.01) Up From $(0.03) YoY, Sales $1.56K

Tuya (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TUYA#NYSE">TUYA</a>) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $0.02 by 50 percent. This is a 50 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $74.69 million which beat the analyst consensus estimate of $73.05 million by 2.24 percent. This is a 21.12 percent increase over sales of $61.66 million the same period last year.

TUYA

Tuya Q1 Adj. EPS $0.03 Beats $0.02 Estimate, Sales $74.69M Beat $73.05M Estimate

Future FinTech Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTFT#NASDAQ">FTFT</a>) reported quarterly losses of $(12.65) per share. This is a 6225 percent decrease over losses of $(0.20) per share from the same period last year. The company reported $552.98 thousand in sales this quarter. This is a 89.21 percent decrease over sales of $5.12 million the same period last year.

FTFT

Future FinTech Gr Q1 EPS $(12.65) Down From $(0.20) YoY, Sales $552.98K Down From $5.12M YoY

Looking into the current session, Danaher Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) shares are trading at $197.77, after a 0.69% spike. Moreover, over the past month, the stock increased by 2.97%, but in the past year, decreased by 25.98%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1747778422_0.png" alt="Past Year Chart" />

<h3>A Look at Danaher P/E Relative to Its Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Danaher has a lower P/E than the aggregate P/E of 44.52 of the Life Sciences Tools &amp; Services industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1747778422_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

P/E Ratio Insights for Danaher

Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) has outperformed the market over the past 20 years by 3.82% on an annualized basis producing an average annual return of 12.12%. Currently, Cigna Group has a market capitalization of $88.11 billion. 
Buying $100 In CI: If an investor had bought $100 of CI stock 20 years ago, it would be worth $987.54 today based on a price of $325.00 for CI at the time of writing.
<h3>Cigna Group's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747778415_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning Cigna Group Stock In The Last 20 Years

Borealis Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRLS#NASDAQ">BRLS</a>) reported quarterly losses of $(0.20) per share. This is a 59.18 percent increase over losses of $(0.49) per share from the same period last year. The company reported $6.85 million in sales this quarter. This is a 13.29 percent decrease over sales of $7.89 million the same period last year.

BRLS

Borealis Foods Q1 EPS $(0.20) Up From $(0.49) YoY, Sales $6.85M Down From $7.89M YoY

Greenwich LifeSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLSI#NASDAQ">GLSI</a>) reported quarterly losses of $(0.25) per share. This is a 31.58 percent decrease over losses of $(0.19) per share from the same period last year.

GLSI

Greenwich LifeSciences Q1 EPS $(0.25) Down From $(0.19) YoY

ASP Isotopes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASPI#NASDAQ">ASPI</a>) reported quarterly losses of $(0.12) per share. This is a 25 percent increase over losses of $(0.16) per share from the same period last year. The company reported $1.10 million in sales this quarter. This is a 31.14 percent increase over sales of $840.35 thousand the same period last year.

ASPI

ASP Isotopes Q1 EPS $(0.12) Up From $(0.16) YoY, Sales $1.10M Up From $840.35K YoY

Society Pass (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOPA#NASDAQ">SOPA</a>) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.20) by 120 percent. This is a 63.64 percent increase over losses of $(1.21) per share from the same period last year. The company reported quarterly sales of $1.47 million which missed the analyst consensus estimate of $2.20 million by 33.00 percent. This is a 20.19 percent decrease over sales of $1.85 million the same period last year.

Earnings Misses

SOPA

Society Pass Q1 EPS $(0.44) Misses $(0.20) Estimate, Sales $1.47M Miss $2.20M Estimate

Legal

Press Releases

ELV Investors Have the Opportunity to Lead the Elevance Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

ELV INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

ELV INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

ELV SHAREHOLDER NOTICE: Suffer Losses on Elevance Health, Inc.? Investors are Alerted to Contact BFA Law by July 11 Class Action Deadline

Deadline Approaching: Elevance Health, Inc. (ELV) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith

CLASS ACTION NOTICE: Berger Montague Advises Elevance Health (NYSE: ELV) Investors to Inquire About a Securities Fraud Class Action

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV

Comments

Elevance Health

뉴스

파트너 / 기고자

벤징가 글로벌